Resources

Welcome to our searchable resource and literature collection on safer supply and related topics.

Found a broken link? Links do move around, so if you find one here that's broken, please let us know through the Contact form.

Opioid use disorder from poppy seed tea successfully treated with buprenorphine in primary care: a case report

Users of poppy seed tea (PST) can consume several hundred morphine milligram equivalents per day, and opioid dependence from PST use can develop.

Original research | 2021

Withdrawal, Clinical guidance, Hesitancy of prescribers , About prescribers, Outcomes, Chronic pain, Substitution/OAT, Stigma

Peer engagement in harm reduction strategies and services: a critical case study and evaluation framework from British Columbia, Canada

This paper aims to describe and evaluate peer engagement in British Columbia from 2010–2014.

Original research | 2016

Evidence base, About PWUD, Peer/PWLLE program involvement

Peer Engagement Principles and Best Practices: A Guide for BC Health Authorities and Other Providers, version 2

Peers can provide insights into the realities of substance use and their local risk environments, and the applicability of programs and policies.

Guidelines | 2018

Equity, Peer/PWLLE program involvement

Preliminary Patterns in Circumstances Surrounding Opioid-Related Deaths in Ontario during the COVID-19 Pandemic

Infographic | 2020

Overdose, Mortality, Evidence base, Safer supply, Advocacy, Social services, Poverty, Housing, Illegal drugs, Sex/Gender

Preliminary Patterns in Circumstances Surrounding Opioid-Related Deaths in Ontario during the COVID-19 Pandemic

Examination of suspected opioid-related deaths in Ontario before and during the pandemic

Report | 2020

Overdose, Mortality, Evidence base, Safer supply, Advocacy, Social services, Poverty, Housing, Illegal drugs, Sex/Gender

Regulation of illegal drugs: an exploration of public health tools

This commentary explores the concept of a regulated market for currently illegal drugs

Commentary | 2004

Evidence base, Policy/Regulatory, Decriminalization/legalization, Advocacy

Safer Opioid Supply Programs (SOS): A Harm Reduction Informed Guiding Document for Primary Care Teams

Despite a current lack of direct evidence, this document has been created to urgently combat overdose deaths. It is informed by existing research and based out of expert opinion.

Guidelines | 2020

Mortality, Clinical guidance, Harm reduction, Safer supply, About prescribers, Transitions in care/treatment, Injecting drugs, Diversion

STOPS: A Journey of Grassroots Overdose Prevention from Northeastern Ontario

Slide deck | 2021

Overdose, Mortality, Harm reduction, Small/medium cities, SCS/OPS

Substance Replacement Therapy in the Context of the COVID-19 Pandemic in Québec: Clinical Guidance for Prescribers

Quebec safe supply clinical guidance for prescribers

Guidelines | 2020

Overdose, Clinical guidance, Harm reduction, Safer supply, About prescribers, Stimulants, Substitution/OAT, Transitions in care/treatment, Injecting drugs

Substance Use (SU) among Women in the Context of the Corollary Pandemics of COVID-19 and Intimate Partner Violence (IPV)

Examines the disparate literatures on 1) disasters/pandemics and intimate partner violence, and 2) on the relationship between intimate partner violence and substance use

Lit review | 2020

Sex/Gender

The drug toxicity and overdose crisis in Canada: a snapshot of what the current data tell us

This article provides a snapshot of data released by Health Canada on opioid- and stimulant-related harms and data from two provinces detailing a concerning trend in the nature of drug toxicity dea

Newsletter | 2021

Overdose, Mortality, Harm reduction, Policy/Regulatory, Safer supply, Decriminalization/legalization, Illegal drugs, Stimulants, SCS/OPS

The legal regulation of drugs and role of government: Perspectives from people who use drugs

This study aimed to examine the views of people who use drugs and who are deeply impacted by drug policies to understand the perceived impacts and role of government under a legalized-regulated market

Original research | 2020

Policy/Regulatory, Decriminalization/legalization, Equity, About PWUD, Peer/PWLLE program involvement

Treatment-seeking behaviour among people with opioid use disorder in the high-income countries: A systematic review and meta-analysis

To determine treatment seeking behaviour in those with opioid use disorder (OUD) in the high-income countries.

Lit review | 2021

About PWUD, Barriers and enablers

Youth Cannabis use and Legalization in Canada – Reconsidering the Fears, Myths and Facts Three Years In

We reconsider the arguments made about the potential consequences of legalization for youth, centered on three key concerns: that prevalence would significantly increase, that there would be greater i

Original research | 2021

Evidence base, Policy/Regulatory, Decriminalization/legalization, Equity, Youth

‘Not at all what I had expected’: Discontinuing treatment with extended-release naltrexone (XR-NTX): A qualitative study

Extended-release naltrexone (XR-NTX), an opioid antagonist, has demonstrated equal treatment outcomes, in terms of safety, opioid use, and retention, to the recommended OMT medication buprenorphine.

Original research | 2021

About PWUD, Substitution/OAT